These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6250860)

  • 1. Naloxone promotes stimulus-evoked vasopressin release in vivo.
    Knepel W; Nutto D; Anhut H; Hertting G
    Eur J Pharmacol; 1980 Aug; 65(4):449-50. PubMed ID: 6250860
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone effects on plasma vasopressin and oxytocin concentrations elevated by histamine, nicotine, isoproterenol and an acute increase in [NaCl] in cerebrospinal fluid.
    Summy-Long JY; Denlinger C; Palm D; Hartman RD; Rosella-Dampman LM
    Neuroendocrinology; 1986; 44(2):157-62. PubMed ID: 3796791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release.
    Zhao BG; Chapman C; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):16-24. PubMed ID: 2845291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.
    Knepel W; Meyer DK
    J Physiol; 1983 Aug; 341():507-15. PubMed ID: 6620188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of naloxone on vasopressin level in the blood of patients with acute and chronic renal failure].
    Grzeszczak W; Kokot F; Duława J; Kuska J
    Pol Arch Med Wewn; 1985 Sep; 74(3):176-80. PubMed ID: 2853864
    [No Abstract]   [Full Text] [Related]  

  • 7. The opioid receptor subtypes mu and kappa, but not delta, are involved in the control of the vasopressin and oxytocin release in the rat.
    Van de Heijning BJ; Koekkoek-Van den Herik I; Van Wimersma Greidanus TB
    Eur J Pharmacol; 1991 Dec; 209(3):199-206. PubMed ID: 1665795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-noradrenergic interactions in the neurohypophysis. II. Does noradrenaline mediate the actions of endogenous opioids on oxytocin and vasopressin release?
    Zhao BG; Chapman C; Brown D; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):25-31. PubMed ID: 2845292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone potentiates the inotropic effects of isoproterenol in vitro by a nonopiate receptor mechanism.
    Lechner RB
    Circ Shock; 1992 Nov; 38(3):157-64. PubMed ID: 1338035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of naloxone on the release of neurohypophysial hormones in normotensive and spontaneously hypertensive rats.
    Rosella-Dampman LM; Emmert SE; Keil LC; Summy-Long JY
    Brain Res; 1985 Jan; 325(1-2):205-14. PubMed ID: 3978414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of specific opioid-receptor antagonist naloxone on rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain) during acute hemorrhagic shock.
    Machuganska A
    Acta Physiol Pharmacol Bulg; 1986; 12(1):62-9. PubMed ID: 3019080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe.
    Bondy CA; Gainer H; Russell JT
    Endocrinology; 1988 Apr; 122(4):1321-7. PubMed ID: 2894296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone does not improve cardiovascular or blunt vasopressin responses in spontaneously hypertensive rats following graded hemorrhage.
    Rockhold RW; Crofton JT; Brooks DP; Share L
    Neuroendocrinology; 1986; 43(6):657-63. PubMed ID: 3020465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
    Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
    Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprenaline and forskolin increase evoked vasopressin release from rat pituitary.
    Racké K; Rothländer M; Muscholl E
    Eur J Pharmacol; 1982 Aug; 82(1-2):97-100. PubMed ID: 6889972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by morphine and beta-endorphin of vasopressin release evoked by electrical stimulation of the rat medial basal hypothalamus in vitro.
    Knepel W; Reimann W
    Brain Res; 1982 Apr; 238(2):484-8. PubMed ID: 6284302
    [No Abstract]   [Full Text] [Related]  

  • 17. Attempted reversal of cocaine-induced antinociceptive effects with naloxone, an opioid antagonist.
    Pertovaara A; Mecke E; Carlson S
    Eur J Pharmacol; 1991 Jan; 192(3):349-53. PubMed ID: 1647316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine has a dual concentration-dependent effect on K(+)-evoked substance P release from rat peripheral airways.
    Cabot PJ; Cramond T; Smith MT
    Pulm Pharmacol Ther; 1997 Aug; 10(4):215-21. PubMed ID: 9695145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis.
    Bicknell RJ; Leng G
    Nature; 1982 Jul; 298(5870):161-2. PubMed ID: 7088170
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasopressin and beta-endorphin release after osmotic and non-osmotic stimuli: effect of naloxone and dexamethasone.
    Knepel W; Nutto D; Anhut H; Hertting G
    Eur J Pharmacol; 1982 Feb; 77(4):299-306. PubMed ID: 6277672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.